A Survey of the Young Person's Experience of Graves' Disease and Its Management | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!
Scientific Articles

A Survey of the Young Person’s Experience of Graves’ Disease and Its Management

key information

source: Clinical Endocrinology

year: 2020

authors: Laura Claire Lane, Judith Rankin, Tim Cheetham

summary/abstract:

Objective: 
A suboptimal quality of life (QoL) has been reported in patients with Graves’ disease treated in adult life, but long-term QoL in those treated in childhood and adolescence is unclear. We wanted to understand how Graves’ disease and its management impact on the physical, psychological and social well-being of young people and their longer-term QoL.

Design, Patients and Measurements: 
Two questionnaires were used to assess QoL and patient experience of Graves’ disease; PedsQL™ Generic Core Scales and a Graves’ disease questionnaire devised for this project. The anonymized questionnaires were sent to young people (<30 years) diagnosed with Graves’ disease in childhood and adolescence and managed at a tertiary paediatric endocrine unit in the North of England. Respondent QoL scores were compared with a healthy UK cohort.

Results: 
Questionnaires were sent to 51 young people, and 26 responded (51%). Graves’ patients reported a lower total QoL score compared with the healthy cohort (p = .003). This was particularly apparent in the psychosocial domain (p = .0016). No patient regretted having definitive treatment (surgery/radioiodine), and all said they would recommend it to others. Half of those who had received definitive treatment still did not feel recovered. There was no difference in the long-term QoL in those who did/did not receive definitive treatment (p = .40).

Conclusions: 
This study highlights short- and long-term impacts on the QoL and general well-being of young people with Graves’ disease. There were no regrets regarding the choice of definitive treatment. This information will help inform the counselling of patients and their families.

organization: The Great North Children's Hospital, UK; Newcastle University, UK

DOI: 10.1111/cen.14359